ClinicalTrials.gg
RecruitingNCT06809309VENT-IHCAUpdated Mar 30, 2026

The Ventilation During In-hospital Cardiac Arrest Study

An observational study in Cardiac Arrest (CA), In-Hospital Cardiac Arrest and Heart Arrest, sponsored by University of Aarhus. Recruiting at 11 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-30.

Sponsored by University of Aarhus · Observational

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
900
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 36 studies in Heart Arrest with a site in Denmark — 6 open to participants now, 11 under way, none of them phase 3. Heart Arrest · Denmark.

Planned enrollment
Largest of 10
900 · median 157
Started
2025
with 2 others
Observational
10 of 36
2 open now
Primary completion
2027-04
later than 6 of 10 live
Registered
34th of 36
by date
Lead sponsor
8 of 36
University of Aarhus

Among the 36 studies in Heart Arrest with a site in Denmark, this one has the largest planned enrollment of the 10 observational ones that give a count, is one of 3 that started in 2025, is one of 10 observational ones, reaches primary completion later than 6 of the 10 other live ones, and was the 34th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

6 of the 36 studies in Heart Arrest with a site in Denmark are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 36 studies in Heart Arrest with a site in Denmark, or all of them as a file.
02

Study summary

The goal of this prospective observational study is to learn how ventilation quality parameters during cardiopulmonary resuscitation (CPR) are associated with short-term survival following in-hospital cardiac arrest of adult patients.

The main questions it aims to answer are:

What ventilation volume during CPR is associated with the highest chance of return of spontaneous circulation (ROSC)? What ventilation rate during CPR is associated with the highest chance of ROSC?

Researchers will compare different levels of ventilation rates and volumes that are blindly measured during CPR to see how the observed rates and volumes are associated with survival outcomes and complications.

03

Conditions studied

  • Cardiac Arrest (CA)
  • In-Hospital Cardiac Arrest
  • Heart Arrest

Browse trials for

Keywords

  • prospective observational study
  • ventilation
  • manual ventilation
  • cardiac arrest
  • in-hospital cardiac arrest (IHCA)
  • bag-valve-mask (BVM)
  • tidal volume
  • ventilation rate
  • intra-arrest ventilation
  • cardiopulmonary ventilation (CPR)
  • resuscitation
  • adult
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients receiving ventilation with a bag-valve-mask (BVM) or advanced airway during cardiopulmonary resuscitation for in-hospital cardiac arrest.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. In-hospital cardiac arrest
  2. Age ≥ 18 years
  3. >1minute of recorded ventilation data

Exclusion criteria

Exclusion Criteria:

  1. Documented do-not-attempt cardiopulmonary resuscitation order
  2. Invasive mechanical circulatory support at the time of the cardiac arrest
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
900 participants (estimated)
Patient registry
No

Groups and cohorts

  • Study cohort

    Adult patients (≥18 years) with in-hospital cardiac arrest receiving cardiopulmonary resuscitation. Groups will be defined based on observed distribution of ventilation parameters (ventilation rate, tidal volume and minute ventilation).

    Other: Positive pressure ventilation during cardiopulmonary resuscitation

Interventions

  • OtherPositive pressure ventilation during cardiopulmonary resuscitation

    The primary exposures of interest are the observed ventilation rate, tidal volume and minute ventilation during cardiopulmonary resuscitation. Ventilation data are obtained by inspiratory and expiratory air flow measurements using the EOlife (Archeon, Besançon, France) to which healthcare providers are blinded.

    Also known as: manual ventilation, artificial ventilation, intra-arrest ventilation, bag-valve-mask ventilation, invasive ventilation

06

What researchers measure

Primary outcomes

  1. Fraction of patients with return of spontaneous circulation (ROSC)

    ROSC is defined as sustained spontaneous circulation with no need for chest compressions for at least 20 minutes.

    Time frame: ROSC is assessed immediately following cardiopulmonary resuscitation.

Secondary outcomes

  1. Fraction of patients surviving until day 30

    Patient survival for at least 30 days following cardiac arrest.

    Time frame: Assessed at day 30 after cardiac arrest.

Other outcomes

  1. Fraction of patients with pulmonary complications

    Composite endpoint of pulmonary complications after return of spontaneous circulation (ROSC) including acute respiratory distress syndrome (ARDS), aspiration, pneumothorax and hemothorax.

    Time frame: From date of ROSC until date of intensive care unit discharge or date of death from any cause, whichever came first, assessed up to 30 days.

  2. Number of days alive without mechanical ventilation

    Days patients are alive without receiving mechanical ventilation after return of spontaneous circulation (ROSC).

    Time frame: From date of ROSC until day 30 or date of death from any cause, whichever came first.

  3. Number of days alive outside the intensive care unit

    Days patients are alive outside of the intensive care unit after return of spontaneous circulation (ROSC).

    Time frame: From date of ROSC until day 90 or date of death from any cause, whichever came first.

07

Study locations

11 of 11 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — The investigators are not permitted to share IPD.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Apr 2027, 26 months after the start.

Of 169 non-industry observational studies under Heart Arrest, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 96. This study's planned 26 months is below that.

Counting every sponsor, half of 176 studies reached it within 41 months; a quarter within 18 and three quarters within 90.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 20, 2025
First posted
Feb 5, 2025
StartActual
Feb 1, 2025
Primary completionEst.
Apr 2027
CompletionEst.
Jun 2027
Last update
Mar 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06809309
Responsible party
Sponsor
First posted
Feb 5, 2025
Start date
Feb 1, 2025
Primary completion
Apr 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Mar 30, 2026

Study contacts

Johannes Wittig, MD
Contact
johannes.wittig@clin.au.dk
+45 78 42 00 00
Kasper G Lauridsen, MD, PhD
Contact
kglerup@clin.au.dk
+45 78 42 00 00
Johannes Wittig, MD
principal investigator · Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark
Kasper G Lauridsen, MD, PhD
principal investigator · Department of Clinical Medicine, Aarhus University, Denmark; Department of Medicine, Randers Regional Hospital, Randers, Denmark; Research Center for Emergency Medicine, Aarhus University Hospital, Denmark;

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion